What percent of GTBP is sold short?

54.6% of GT Biopharma (GTBP) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is GTBP a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for GT Biopharma (GTBP).

GTBP Short Volume Hit 54.6%

Also trades as: GTBP.PA (PAR)

$6.10

-0.10 (-1.61%)

Weekly Expected Move ±32.3%

$2 $4 $6 $8 $10

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 23 · $7.7M mcap · 1M float · 4.31% daily turnover · Short 58% of daily vol

Short Volume Summary

2026-10-01

36.0%

Short Ratio

of total volume

57.7%

20-Day Avg

53.2%

50-Day Avg

▼ Falling

5-Day Trend

0.0M

Short Volume

0.0M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	6,415	18,660	34.4%
NYSE	240	310	77.4%
BATS	270	271	99.7%

GTBP Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet